|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 10197 |
FusionGeneSummary for DNAJA2_ANKRD11 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DNAJA2_ANKRD11 | Fusion gene ID: 10197 | Hgene | Tgene | Gene symbol | DNAJA2 | ANKRD11 | Gene ID | 10294 | 29123 |
| Gene name | DnaJ heat shock protein family (Hsp40) member A2 | ankyrin repeat domain 11 | |
| Synonyms | CPR3|DJ3|DJA2|DNAJ|DNJ3|HIRIP4|PRO3015|RDJ2 | ANCO-1|ANCO1|LZ16|T13 | |
| Cytomap | 16q11.2 | 16q24.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | dnaJ homolog subfamily A member 2DnaJ (Hsp40) homolog, subfamily A, member 2HIRA interacting protein 4cell cycle progression 3 proteincell cycle progression restoration gene 3 proteinrenal carcinoma antigen NY-REN-14 | ankyrin repeat domain-containing protein 11ankyrin repeat-containing cofactor 1nasopharyngeal carcinoma susceptibility proteintruncated ankyrin repeat domain 11 aberrant transcript 1truncated ankyrin repeat domain 11 aberrant transcript 2 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | O60884 | Q6UB99 | |
| Ensembl transtripts involved in fusion gene | ENST00000317089, | ENST00000378330, ENST00000301030, ENST00000563291, ENST00000567736, | |
| Fusion gene scores | * DoF score | 5 X 5 X 2=50 | 12 X 14 X 4=672 |
| # samples | 6 | 16 | |
| ** MAII score | log2(6/50*10)=0.263034405833794 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(16/672*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: DNAJA2 [Title/Abstract] AND ANKRD11 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | DNAJA2 | GO:0042026 | protein refolding | 21231916 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF326211 | DNAJA2 | chr16 | 46990865 | + | ANKRD11 | chr16 | 89350945 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000317089 | ENST00000378330 | DNAJA2 | chr16 | 46990865 | + | ANKRD11 | chr16 | 89350945 | - |
| intron-3CDS | ENST00000317089 | ENST00000301030 | DNAJA2 | chr16 | 46990865 | + | ANKRD11 | chr16 | 89350945 | - |
| intron-intron | ENST00000317089 | ENST00000563291 | DNAJA2 | chr16 | 46990865 | + | ANKRD11 | chr16 | 89350945 | - |
| intron-intron | ENST00000317089 | ENST00000567736 | DNAJA2 | chr16 | 46990865 | + | ANKRD11 | chr16 | 89350945 | - |
Top |
FusionProtFeatures for DNAJA2_ANKRD11 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| DNAJA2 | ANKRD11 |
| Co-chaperone of Hsc70. Stimulates ATP hydrolysis and thefolding of unfolded proteins mediated by HSPA1A/B (in vitro)(PubMed:24318877). {ECO:0000269|PubMed:24318877}. | Chromatin regulator which modulates histone acetylationand gene expression in neural precursor cells (By similarity). Mayrecruit histone deacetylases (HDACs) to the p160coactivators/nuclear receptor complex to inhibit ligand-dependenttransactivation (PubMed:15184363). Has a role in proliferation anddevelopment of cortical neural precursors (PubMed:25556659). Mayalso regulate bone homeostasis (By similarity).{ECO:0000250|UniProtKB:E9Q4F7, ECO:0000269|PubMed:15184363,ECO:0000269|PubMed:25556659}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DNAJA2_ANKRD11 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for DNAJA2_ANKRD11 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DNAJA2_ANKRD11 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for DNAJA2_ANKRD11 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | ANKRD11 | C0005944 | Metabolic Bone Disorder | 1 | CTD_human |
| Tgene | ANKRD11 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|